Bristol Myers beats $6.4 billion lawsuit over delayed cancer drug
(Reuters) – Bristol Myers Squibb won the dismissal on Monday of a $6.4 billion lawsuit claiming it cheated former Celgene…
(Reuters) – Bristol Myers Squibb won the dismissal on Monday of a $6.4 billion lawsuit claiming it cheated former Celgene…
By Michael S. Derby NEW YORK (Reuters) – The Federal Reserve Bank of New York said Monday that eligible firms…
By Tim Reid WASHINGTON (Reuters) – Donald Trump on Saturday deployed some of his harshest rhetoric against immigrants who have…
By Haripriya Suresh and Praveen Paramasivam BENGALURU (Reuters) – Indian authorities are set to begin a forensic investigation into the…
By Ernest Scheyder (Reuters) – Freeport-McMoRan is turbo-charging its copper output across three continents with no plans to join a…
By Krystal Hu and Kenrick Cai (Reuters) – Thrive Capital is investing more than $1 billion of OpenAI’s current $6.5…
(Reuters) – Apple has left negotiations to participate in an OpenAI funding round expected to raise about $6.5 billion, the…
By Supantha Mukherjee and Anna Tong STOCKHOLM/SAN FRANCISCO (Reuters) – In the early years, getting AI models like ChatGPT or…
TUCSON, Arizona (Reuters) – U.S. Democratic presidential candidate Kamala Harris will call for tighter asylum and border control measures for…
(Reuters) – Alphabet plans to invest $3.3 billion in South Carolina to build two new data centers, CEO Sundar Pichai…